Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of June 2026
Monica McNeil @Monica McNeil
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,385,333talents

Virtual portfolio value:

$5,320,709talents

Net overall return per annum:

19.25%

AYA current rank order:

#10

Asset investment philosophy:
Monica McNeil trades U.S. stocks with the top #126 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
HAO Haoxi Health Technology Limited Class A Ordinary Shares $0.15 $2.50 90,600 +1,566.67% $212,910
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 27,508 +2,108.33% $208,786
XBIOW Xenetic Biosciences Inc. Warrants $2.00 $23.16 5,633 +1,058.00% $119,194
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 37,750 +833.33% $113,250
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 37,750 +833.33% $113,250
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 84,713 +793.33% $100,808
VATE INNOVATE Corp. Common Stock $0.53 $4.14 23,975 +681.13% $86,550
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,672 +660.87% $60,922
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 1,251 +589.24% $51,379
GLOB Globant S.A. Common Shares $34.57 $215.99 252 +524.79% $45,718
Sum $1,112,767

Top 10 current stock portfolio positions as of June 2026Strategy

Symbol Company Price Position Capitalization
MGNI Magnite Inc. Common Stock $18.73 4,602 $86,195
HIMS Hims & Hers Health Inc. Class A Common Stock $33.94 2,522 $85,596
TCI Transcontinental Realty Investors Inc. Common Stock $49.85 1,701 $84,794
TRVI Trevi Therapeutics Inc. Common Stock $18.15 4,664 $84,651
LIF Life360 Inc. Common Stock $53.08 1,552 $82,380
MHH Mastech Digital Inc Common Stock $7.71 10,621 $81,887
NPO Enpro Inc. Common Stock $379.26 214 $81,161
ALMS Alumis Inc. Common Stock $26.40 3,053 $80,599
FNLC First Bancorp Inc (ME) Common Stock $35.51 2,265 $80,430
MIRM Mirum Pharmaceuticals Inc. Common Stock $123.77 649 $80,326
Sum $828,019

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Blog+More

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk.

Monica McNeil

2018-09-05 08:34:00 Wednesday ET

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk.

Citron Research short-sellers initiate a class-action lawsuit against Tesla and its executive chairman Elon Musk because he might have deliberately orchestr

+See More

President Trump targets Amazon in his call for U.S. Postal Service to charge higher delivery prices on the ecommerce giant.

Laura Hermes

2018-01-03 08:38:00 Wednesday ET

President Trump targets Amazon in his call for U.S. Postal Service to charge higher delivery prices on the ecommerce giant.

President Trump targets Amazon in his call for U.S. Postal Service to charge high delivery prices on the ecommerce giant. Trump picks another fight with an

+See More

Kobe Bryant and several other star athletes have been smart savvy investors.

Charlene Vos

2019-08-08 09:35:00 Thursday ET

Kobe Bryant and several other star athletes have been smart savvy investors.

Kobe Bryant and several other star athletes have been smart savvy investors. In collaboration with former Web.com CEO Jeff Stibel, the NBA champion invests

+See More

Can the Chinese renminbi become the next dual global reserve currency in addition to the American dollar?

Daphne Basel

2020-08-01 07:28:00 Saturday ET

Can the Chinese renminbi become the next dual global reserve currency in addition to the American dollar?

Technological advances, geopolitical risks, and pandemic outbreaks cannot shake investor confidence in the American dollar as the global reserve currency.

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

The U.S. further derisks and decouples from China.

Peter Prince

2023-05-31 03:15:40 Wednesday ET

The U.S. further derisks and decouples from China.

The U.S. further derisks and decouples from China.   Why does the U.S. seek to further economically decouple from China? In recent times, th

+See More